EDITORIAL
Year : 2020 | Volume
: 10 | Issue : 4 | Page : 159--162
What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness
Andrew C Miller1, Shobi Venkatachalam2
1 Department of Emergency Medicine, Nazareth Hospital, Philadelphia, PA, USA
2 Department of Internal Medicine, Nazareth Hospital, Philadelphia, PA, USA
Correspondence Address:
Dr. Andrew C Miller
Department of Emergency Medicine, Nazareth Hospital, 2601 Holme Avenue, 3rd Floor, Marian Building, Philadelphia, PA 19152
USA
How to cite this article:
Miller AC, Venkatachalam S. What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness.Int J Crit Illn Inj Sci 2020;10:159-162
|
How to cite this URL:
Miller AC, Venkatachalam S. What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness. Int J Crit Illn Inj Sci [serial online] 2020 [cited 2021 Jan 19 ];10:159-162
Available from: https://www.ijciis.org/article.asp?issn=2229-5151;year=2020;volume=10;issue=4;spage=159;epage=162;aulast=Miller;type=0 |
|
